Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Moodys
Baxter
McKesson
Deloitte
Medtronic
Fish and Richardson
US Department of Justice
Queensland Health
Citi

Generated: January 20, 2018

DrugPatentWatch Database Preview

Oxytetracycline - Generic Drug Details

« Back to Dashboard

Medical Subject Heading (MeSH) Categories for oxytetracycline

US Patents and Regulatory Information for oxytetracycline

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer TERRAMYCIN oxytetracycline hydrochloride INJECTABLE;INJECTION 060586-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pfizer TERRAMYCIN oxytetracycline hydrochloride CAPSULE;ORAL 050286-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ferrante OXY-KESSO-TETRA oxytetracycline hydrochloride CAPSULE;ORAL 060179-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Casper Pharma Llc TERRAMYCIN W/ POLYMYXIN B SULFATE oxytetracycline hydrochloride; polymyxin b sulfate OINTMENT;OPHTHALMIC 061015-001 Approved Prior to Jan 1, 1982 RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pfizer TERRAMYCIN-POLYMYXIN oxytetracycline hydrochloride; polymyxin b sulfate TABLET;VAGINAL 061009-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Purepac Pharm OXYTETRACYCLINE HYDROCHLORIDE oxytetracycline hydrochloride CAPSULE;ORAL 060634-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pfizer TERRAMYCIN oxytetracycline calcium SYRUP;ORAL 060595-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Proter OXYTETRACYCLINE HYDROCHLORIDE oxytetracycline hydrochloride CAPSULE;ORAL 060869-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Impax Labs OXYTETRACYCLINE HYDROCHLORIDE oxytetracycline hydrochloride CAPSULE;ORAL 060760-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pfizer TERRAMYCIN oxytetracycline hydrochloride INJECTABLE;INJECTION 060586-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Harvard Business School
Queensland Health
Merck
Cerilliant
Medtronic
UBS
Teva
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot